Premier Biomedical Inc. (BIEI)
OTC PINK OTC PINK Primary Summary
Premier Graphene Inc. (OTC: BIEI) Currently Anticipates Reporting First Profitable Quarter in Company History
Business Model Developed by Strategic Joint Venture between Premier and HGI Drives Historic Financial Milestone and Positions Premier for Continued Growth and Profitability PR Audio: Mexico City, Mexico, June 18, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Premier Graphene Inc.
Premier Graphene Inc. (OTC:BIEI) Reports Progress Securing Government Contracts in Latin American Countries, Receiving a Specific Purchase Order Request from their Authorized Personnel
Having Successfully Secured other significant Authorizations and Registrations, Premier now Announces Near-Term Initiative to Obtain ITAR Registration, Advancing a Secure Entry Into Defense Procurement Markets within the United States and other countries EL CENTRO, Calif., Jan. 27, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Premier Graphene Inc.
President Pedro Méndez of Premier Graphene Inc. (BIEI) and HGI Industrial Technologies – Presenters at the International Cannabis & Industrial Hemp Forum
The co-presenters, in coordination with Premier Graphene Inc. and HGI Industrial Technologies, uniquely position BIEI for success Takeaways: MEXICO CITY, Dec. 23, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – President Pedro Méndez, representing Premier Graphene Inc.
Premier Biomedical Inc. (BIEI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Premier Biomedical Inc. ever had a stock split?
Premier Biomedical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | David Caplan CEO | OTC PINK Exchange | 74048K203 CUSIP |
| US Country | 4 Employees | - Last Dividend | 27 Jun 2018 Last Split | - IPO Date |
Overview
Premier Biomedical, Inc. is a distinguished research-oriented company, dedicated to the discovery and development of innovative medical solutions for a range of serious conditions. Since its inception in 2010, headquartered in Jackson Center, Pennsylvania, Premier Biomedical has been at the forefront of creating cutting-edge therapeutic products aimed at addressing the unmet medical needs in areas such as Post-Traumatic Stress Disorder (PTSD), cancer, and a variety of other debilitating diseases. Through its unique approach combining scientific rigor with compassionate care, Premier Biomedical is steadfast in its mission to improve patient outcomes and quality of life.
Products and Services
- Pain Management Products: Premier Biomedical offers a suite of pain management solutions incorporating hemp oil extracts. These include:
- Pain Relief Patch: A transdermal patch designed for targeted pain relief.
- Water-based and Oil-based Roll-on Applicators: For easy and direct application to painful areas.
- Oil-based Pump Spray Applicators: Convenient spray formats for easy application.
- Ointments: Formulated for topical use, providing relief from discomfort.
- Hemp Oil Products: In addition to pain management solutions, Premier Biomedical is expanding its product line to include a wide range of hemp oil-based products such as:
- Anti-Pain Patch: A specially designed patch infused with hemp oil for pain relief.
- Roll-on Topical Products: Easy to use roll-on products for effective pain management.
- Sprays: Hemp oil-based sprays for convenient application.
- Ointments: Topical ointments designed for targeted relief.
- Tincture Drop Product: A liquid solution for oral use.
- Hemp Oil Capsule: Oral capsules containing hemp oil for systemic relief.
- Pet Product: Specially formulated hemp oil products for pets.
- Sequential-Dialysis Technique: A revolutionary approach under development by Premier Biomedical for the treatment of various life-threatening conditions including cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other cancers. This technique promises a new horizon in medical science by potentially isolating and eliminating disease-causing elements from the blood.
- Feldetrex: An innovative drug candidate aimed at treating multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Feldetrex represents Premier Biomedical's dedication to addressing complex neurological and pain-related conditions through groundbreaking pharmaceutical development.
